Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.1500
-0.0100 (-6.25%)
Apr 28, 2026, 4:10 PM AEST
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 147.63 million as of April 28, 2026. Its market cap has increased by 839.19% in one year.
Market Cap
147.63M
Enterprise Value
152.84M
Revenue
18.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since July 5, 2021, ASX:LDX's market cap has decreased from 196.70M to 147.63M, a decrease of -24.95%. That is a compound annual growth rate of -5.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 138.40M | -38.31% |
| Dec 31, 2025 | 224.36M | 756.38% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
| Jul 5, 2021 | 196.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyNovo | 694.30M |
| Aroa Biosurgery | 183.33M |
| EMVision Medical Devices | 167.29M |
| SomnoMed | 136.93M |
| Epiminder | 129.81M |
| Cleo Diagnostics | 93.07M |
| Compumedics | 56.93M |
| HeraMED | 56.59M |